As mRNA continues to gain prominence in medicine, securing a swift and reliable supply of synthetic template DNA to produce mRNA sequences remains a critical challenge for every mRNA vaccine and therapeutic development program. While the conventional cell-based cloning method often creates time consuming and error prone bottlenecks, a new cell-free approach puts mRNA production on the fast track.
Download this poster from Elegen to learn about the synthetic mRNA development process and discover how cell-free gene synthesis shortens the mRNA production timeline, accelerating the delivery of mRNA vaccines and therapeutics to the clinic.